OM Outset Medical, Inc.

Fundamentals / CIK 0001484612 / USD

Outset Medical, Inc. reported $122.0M in revenue and a net loss of $71.14M for the trailing twelve months ended September 30, 2026 (up 14.2% year over year), with a 42.0% gross margin and a -51.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$146.7M$73.37M$0-$172.6MFY 2018 Revenue: $2.01MFY 2018 Net Income: -$49.78M2018FY 2019 Revenue: $15.08MFY 2019 Net Income: -$68.30M2019FY 2020 Revenue: $49.94MFY 2020 Net Income: -$121.5M2020FY 2021 Revenue: $102.6MFY 2021 Net Income: -$131.9M2021FY 2022 Revenue: $115.4MFY 2022 Net Income: -$163.0M2022FY 2023 Revenue: $130.4MFY 2023 Net Income: -$172.8M2023FY 2024 Revenue: $113.7MFY 2024 Net Income: -$128.0M2024FY 2025 Revenue: $119.5MFY 2025 Net Income: -$81.65M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $119.5M $113.7M $130.4M $115.4M $102.6M $49.94M $15.08M $2.01M
Cost of Revenue $72.72M $75.12M $101.4M $97.54M $94.99M $62.97M $32.88M $8.12M
Gross Profit $46.75M $38.56M $29.00M $17.83M $7.61M -$13.04M -$17.80M -$6.12M
Research & Development $21.23M $38.40M $57.31M $48.85M $36.74M $28.85M $23.33M $22.92M
Selling, General & Admin $92.22M $113.5M $141.5M $130.0M $101.4M $75.58M $29.18M $17.53M
Total Operating Expenses $113.5M $151.9M $198.8M $178.9M $138.1M $104.4M $52.51M $40.45M
Operating Income -$66.71M -$113.4M -$169.8M -$161.0M -$130.5M -$117.5M -$70.31M -$46.56M
EBITDA -$62.37M -$107.6M -$164.0M -$155.8M -$125.4M -$114.3M -$68.82M -$45.49M
Interest Expense $13.95M $23.87M $12.68M $3.57M $1.72M $2.89M $4.26M $4.64M
Income Before Tax -$80.94M -$127.5M -$172.3M -$162.7M -$131.7M -$121.5M -$68.28M -$49.76M
Income Tax Expense $718K $491K $523K $295K $199K $0 $20K $25K
Net Income -$81.65M -$128.0M -$172.8M -$163.0M -$131.9M -$121.5M -$68.30M -$49.78M
Basic EPS -$5.37 -$36.96 -$52.28 -$50.70 -$43.35 -$72.75 -$1,493.70 -$1,511.25
Diluted EPS -$5.37 -$36.96 -$52.28 -$50.70 -$43.35 -$72.75 -$1,493.70 -$1,511.25
Basic Shares Outstanding 15.2K 3.5K 3.3K 3.2K 3.0K 1.1K 57.2K 48.3K
Diluted Shares Outstanding 15.2K 3.5K 3.3K 3.2K 3.0K 1.1K 57.2K 48.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $33.60M $31.64M $27.86M $28.87M $29.43M $31.42M $29.75M $29.47M
Cost of Revenue $19.93M $18.35M $15.77M $16.64M $17.84M $19.55M $18.69M $18.72M
Gross Profit $13.67M $13.28M $12.10M $12.23M $11.59M $11.87M $11.07M $10.75M
Research & Development $5.90M $5.45M $5.62M $5.05M $5.38M $5.29M $5.51M $7.89M
Selling, General & Admin $20.04M $23.51M $23.40M $24.80M $22.03M $23.44M $21.95M $24.72M
Total Operating Expenses $25.94M $28.96M $29.01M $29.86M $27.40M $28.73M $27.46M $32.61M
Operating Income -$12.27M -$15.68M -$16.92M -$17.63M -$15.81M -$16.86M -$16.40M -$21.86M
EBITDA -$11.60M -$15.05M -$16.12M -$16.75M -$14.80M -$15.71M -$15.11M -$20.45M
Interest Expense $3.50M $3.44M $3.37M $3.44M $3.48M $3.48M $3.56M $5.83M
Income Before Tax -$14.53M -$17.76M -$18.76M -$19.40M -$17.43M -$18.44M -$25.67M -$25.64M
Income Tax Expense $153K $220K $217K $95K $404K $104K $115K -$4.0K
Net Income -$14.69M -$17.98M -$18.98M -$19.49M -$17.84M -$18.54M -$25.78M -$25.64M
Basic EPS -$0.78 -$0.97 -$1.03 -- -$1.00 -$1.04 -$3.66 --
Diluted EPS -$0.78 -$0.97 -$1.03 -- -$1.00 -$1.04 -$3.66 --
Basic Shares Outstanding 18.8K 18.6K 18.4K -- 17.8K 17.7K 7.0K --
Diluted Shares Outstanding 18.8K 18.6K 18.4K -- 17.8K 17.7K 7.0K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $35.01M $124.0M $68.51M $73.22M $182.3M $295.0M $36.93M
Short-Term Investments $133.9M $34.67M $134.8M $214.3M $157.1M $19.90M $33.15M
Cash & Short-Term Investments $168.9M $158.7M $203.3M $287.5M $339.5M $314.9M $70.08M
Accounts Receivable, Net $28.33M $35.62M $32.98M $28.07M $25.60M $6.47M $3.91M
Inventory $47.61M $59.39M $49.22M $51.48M $39.19M $18.38M $4.60M
Total Current Assets $250.9M $258.2M $291.2M $373.6M $409.8M $345.9M $79.65M
Property, Plant & Equipment, Net $4.67M $8.13M $13.27M $15.88M $12.96M $15.00M $7.89M
Other Non-Current Assets $317K $2.17M $605K $1.17M $156K $1.36M $82K
Total Non-Current Assets $13.61M $17.57M $22.58M $26.47M $53.66M $57.92M $8.72M
Total Assets $264.5M $275.8M $313.8M $400.1M $463.5M $403.8M $88.37M
Accounts Payable $554K $3.86M $5.83M $603K $1.76M $4.95M $4.96M
Short-Term Debt -- -- -- $4.75M $2.02M $2.02M $7.50M
Deferred Revenue (Current) $13.79M $12.75M $11.73M $8.66M $6.34M $3.20M $883K
Other Current Liabilities $4.07M $3.09M $5.76M $7.11M $4.02M $1.40M $1.14M
Total Current Liabilities $37.63M $45.38M $55.32M $51.95M $51.70M $36.69M $24.91M
Long-Term Debt $96.24M $197.4M $130.1M $96.34M $29.76M $29.67M $21.56M
Deferred Revenue (Non-Current) $406K $844K $101K $151K $312K $570K $134K
Total Non-Current Liabilities $99.91M $203.6M $135.6M $102.2M $37.69M $38.53M $26.20M
Total Liabilities $137.5M $249.0M $190.9M $154.1M $89.38M $75.22M $51.11M
Total Debt (incl. Leases) $101.2M $201.9M $136.2M $108.0M $39.83M $40.62M $29.07M
Common Stock $18K $4.0K $50K $48K $47K $43K $1.0K
Retained Earnings -$1.17B -$1.09B -$961.7M -$789.0M -$626.0M -$494.1M -$372.6M
Accumulated Other Comp. Income $172K $42K $68K -$564K -$184K $1.0K $22K
Total Stockholders' Equity $127.0M $26.82M $122.9M $246.0M $374.1M $328.6M -$372.2M
Total Equity $127.0M $26.82M $122.9M $246.0M $374.1M $328.6M -$372.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $33.94M $35.01M $30.56M $35.01M $36.44M $39.56M $75.93M $124.0M
Short-Term Investments $102.7M $112.2M $126.1M $133.9M $142.2M $144.5M $113.1M $34.67M
Cash & Short-Term Investments $136.6M $147.2M $156.7M $168.9M $178.6M $184.1M $189.0M $158.7M
Accounts Receivable, Net $30.41M $29.22M $25.32M $28.33M $32.96M $34.89M $36.89M $35.62M
Inventory $44.99M $47.31M $49.65M $47.61M $49.29M $52.25M $55.77M $59.39M
Total Current Assets $216.2M $227.8M $236.7M $250.9M $265.4M $275.6M $286.6M $258.2M
Property, Plant & Equipment, Net $3.54M $3.71M $4.07M $4.67M $5.25M $6.17M $6.94M $8.13M
Other Non-Current Assets $447K $411K $353K $317K $538K $560K $818K $2.17M
Total Non-Current Assets $14.19M $14.54M $12.74M $13.61M $11.89M $13.22M $14.65M $17.57M
Total Assets $230.4M $242.4M $249.5M $264.5M $277.3M $288.8M $301.2M $275.8M
Accounts Payable $4.29M $4.46M $1.44M $554K $1.72M $1.45M $1.17M $3.86M
Deferred Revenue (Current) $13.47M $14.04M $12.64M $13.79M $14.90M $14.01M $13.19M $12.75M
Other Current Liabilities $5.28M $6.02M $5.08M $4.07M $3.56M $3.19M $2.73M $3.09M
Total Current Liabilities $44.45M $43.89M $37.61M $37.63M $37.45M $36.91M $34.22M $45.38M
Long-Term Debt $98.37M $97.65M $96.94M $96.24M $95.52M $94.81M $94.11M $197.4M
Deferred Revenue (Non-Current) $221K $302K $366K $406K $676K $587K $804K $844K
Total Non-Current Liabilities $102.6M $102.2M $100.2M $99.91M $97.44M $97.11M $97.12M $203.6M
Total Liabilities $147.1M $146.0M $137.8M $137.5M $134.9M $134.0M $131.3M $249.0M
Total Debt (incl. Leases) $104.8M $104.4M $101.6M $101.2M $98.68M $98.43M $98.17M $201.9M
Common Stock $19K $19K $18K $18K $18K $18K $18K $4.0K
Retained Earnings -$1.22B -$1.21B -$1.19B -$1.17B -$1.15B -$1.13B -$1.12B -$1.09B
Accumulated Other Comp. Income -$244K -$136K -$73K $172K $157K $49K $88K $42K
Total Stockholders' Equity $83.31M $96.34M $111.7M $127.0M $142.4M $154.8M $169.9M $26.82M
Total Equity $83.31M $96.34M $111.7M $127.0M $142.4M $154.8M $169.9M $26.82M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$81.65M -$128.0M -$172.8M -$163.0M -$131.9M -$121.5M -$68.30M -$49.78M
Depreciation & Amortization $4.34M $5.73M $5.81M $5.17M $5.16M $3.16M $1.48M $1.07M
Stock-Based Compensation $15.62M $29.36M $38.63M $27.20M $17.45M $21.44M $883K $788K
Change in Receivables $3.77M -$5.01M -$5.09M -$2.51M -$19.14M -$2.57M -$2.89M -$552K
Change in Inventory $11.79M -$10.86M $1.65M -$14.73M -$22.04M -$16.29M -$5.02M -$2.21M
Change in Payables -$3.29M -$1.95M $5.31M -$1.28M -$3.07M $737K $802K $2.67M
Operating Cash Flow -$46.33M -$116.3M -$131.4M -$145.7M -$130.3M -$99.02M -$70.29M -$46.44M
Capital Expenditure -$798K -$912K -$3.44M -$8.32M -$3.11M -$9.08M -$3.29M -$1.77M
Free Cash Flow -$47.12M -$117.2M -$134.8M -$154.1M -$133.4M -$108.1M -$73.58M -$48.21M
Purchases of Investments -$222.0M -$156.6M -$172.3M -$261.2M -$178.4M -$32.88M -$91.88M --
Sales & Maturities of Investments $125.1M $261.4M $258.8M $203.2M $39.03M $45.91M $169.5M --
Investing Cash Flow -$97.68M $103.9M $83.03M -$66.30M -$142.5M $3.95M $74.30M -$68.78M
Common Stock Issued -- -- $0 $0 $149.1M $254.8M -- --
Financing Cash Flow $55.50M $67.87M $43.65M $72.90M $160.1M $385.7M $249K $134.9M
Net Change in Cash -$88.51M $55.51M -$4.70M -$139.1M -$112.6M $290.6M $4.25M $19.65M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$14.69M -$17.98M -$18.98M -$19.49M -$17.84M -$18.54M -$25.78M -$25.64M
Depreciation & Amortization $666K $627K $795K $881K $1.01M $1.16M $1.29M $1.41M
Stock-Based Compensation $1.69M $2.70M $3.45M $4.06M $5.08M $3.50M $2.98M $4.95M
Change in Receivables -$2.09M -$5.04M $3.41M $1.77M $2.90M $574K -$1.47M -$1.92M
Change in Inventory $2.19M $2.34M -$2.24M $1.49M $3.00M $3.61M $3.69M $2.13M
Change in Payables -$96K $2.97M $865K -$1.13M $338K $270K -$2.77M -$441K
Operating Cash Flow -$10.38M -$9.63M -$12.84M -$9.52M -$6.32M -$4.82M -$25.66M -$16.49M
Capital Expenditure -$109K -$111K -$65K -$223K -$160K -$292K -$123K -$43K
Free Cash Flow -$10.49M -$9.75M -$12.91M -$9.74M -$6.48M -$5.12M -$25.79M -$16.53M
Purchases of Investments -$24.09M -$18.65M -$22.89M -$28.22M -$40.09M -$57.32M -$96.33M -$6.12M
Sales & Maturities of Investments $33.87M $32.92M $30.86M $37.03M $43.22M $26.45M $18.38M $114.3M
Investing Cash Flow $9.66M $14.17M $7.90M $8.59M $2.97M -$31.16M -$78.08M $108.2M
Financing Cash Flow -$56K -$88K $501K $0 $231K -$384K $55.66M -$938K
Net Change in Cash -$771K $4.44M -$4.44M -$931K -$3.12M -$36.37M -$48.09M $90.73M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 39.1% 33.9% 22.2% 15.5% 7.4% -26.1% -118.1% -304.7%
Operating Margin -55.8% -99.7% -130.2% -139.6% -127.2% -235.2% -466.3% -2320.0%
Net Profit Margin -68.3% -112.6% -132.5% -141.2% -128.6% -243.3% -453.0% -2480.3%
Return on Equity (ROE) -64.3% -477.2% -140.6% -66.2% -35.3% -37.0% -- --
Return on Assets (ROA) -30.9% -46.4% -55.1% -40.7% -28.5% -30.1% -77.3% --
Current Ratio 6.67x 5.69x 5.26x 7.19x 7.93x 9.43x 3.20x --
Quick Ratio 5.40x 4.38x 4.37x 6.20x 7.17x 8.93x 3.01x --
Debt to Equity 0.80x 7.53x 1.11x 0.44x 0.11x 0.12x -- --
Revenue Growth (YoY) +5.1% -12.8% +13.0% +12.4% +105.5% +231.2% +651.3% --
Gross Profit Growth (YoY) +21.2% +33.0% +62.6% +134.4% -- -- -- --
5Y Revenue / Share Growth -82.8% +12354.3% +94899.8% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 42.0% 41.8% 40.6% 39.1% 37.7% 36.5% 35.9% 33.9%
Operating Margin -51.2% -56.1% -57.2% -55.8% -59.1% -66.2% -80.6% -99.7%
Net Profit Margin -58.3% -63.1% -63.7% -68.3% -73.1% -82.1% -98.7% -112.6%
Return on Equity (ROE) -85.4% -77.1% -67.0% -64.3% -61.7% -63.3% -67.0% -477.2%
Return on Assets (ROA) -30.9% -30.6% -30.0% -30.9% -31.7% -33.9% -37.8% -46.4%
Current Ratio 4.86x 5.19x 6.29x 6.67x 7.09x 7.47x 8.37x 5.69x
Quick Ratio 3.85x 4.11x 4.97x 5.40x 5.77x 6.05x 6.74x 4.38x
Debt to Equity 1.26x 1.08x 0.91x 0.80x 0.69x 0.64x 0.58x 7.53x
Revenue Growth (YoY) +14.2% +0.7% -6.3% -2.0% +2.7% +14.7% +5.6% -3.4%
Gross Profit Growth (YoY) +18.0% +11.9% +9.3% +13.8% +18.0% +21.3% +34.7% +39.4%
Source: SEC EDGAR CompanyFacts (CIK 0001484612) · from December 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:50 UTC · Open in terminal